Ligand · NU2
NU2 · (3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione
NU2, (3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione (C27 H34 N4 O5, 494.6 g/mol), in the MolNFT structures on…
- Component
- NU2
- Formula
- C27 H34 N4 O5
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
NU2 in 1 structure; the first of them:
- 6TPK · Crystal structure of the human oxytocin receptor · NU2 A1501 · binds GLN92, LYS116, GLN119, MET123, GLN171, PHE175, ILE201, ILE204 and 5 more
Residues it binds most
GLN 1, PHE 1, ILE 1, ALA 1, LYS 1, MET 1, TRP 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.